featured
DNA-Repair Gene Mutations in Men With mCRPC Receiving First-Line Abiraterone and Enzalutamide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Germline DNA-Repair Gene Mutations and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide
Eur Urol 2018 Aug 01;74(2)218-225, ES Antonarakis, C Lu, B Luber, C Liang, H Wang, Y Chen, JL Silberstein, D Piana, Z Lai, Y Chen, WB Isaacs, J LuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.